SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap is trending after reporting strong earnings and authorizing a significant share buyback, which has paradoxically seen its stock decline, igniting community debate over executive stock-based compensation and dilution concerns amidst optimism for its AI/AR Smartglasses innovation and competition from rivals like Meta.

Kyndryl Holdings, Inc. is a technology services company, which engages in the provision of infrastructure services. It operates through the following segments: United States, Japan, Principal Markets, and Strategic Markets. The Principal Markets segment represents the aggregation of operations in Australia, New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, the United Kingdom, and Ireland. The company was founded on December 4, 2020 and is headquartered in New York, NY.

Kyndryl Holdings Inc

Kyndryl (KD) plunged after its CFO and general counsel exited amidst an SEC investigation and accounting review uncovering internal control weaknesses, leading to a fierce debate among investors questioning potential fraud versus an extreme, oversold market reaction.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is trending after its Q4 earnings report, which, despite profitability, featured a revenue miss and conservative guidance driven by prudent risk management, prompting a sharp sell-off that the community largely decries as an exaggerated market overreaction to an already undervalued AI-powered fintech. Many investors are viewing the dip as a significant buying opportunity amidst high short interest and broader pressures on the fintech sector.

GhostwareOS (GHOST) is the Full-Stack Privacy Layer of Solana — a next-generation AI-driven infrastructure for encrypted communication, anonymous identity management, and untraceable transactions. By combining advanced zero-knowledge protocols with autonomous AI routing, GhostwareOS allows users and developers to operate invisibly across Web3. It powers decentralized apps that demand true digital anonymity, scalable privacy, and zero metadata leakage — restoring control to users in an overexposed internet age.

Ghost

GHOST CRYPTO is trending as a Solana-backed privacy protocol, gaining attention for its utility in private payments and a highly anticipated revenue share model for holders. The community is actively discussing its low market cap and potential to become the default privacy layer within the expanding Solana ecosystem, despite some skepticism.

Ichor Holdings Ltd. engages in designing, engineering, and manufacturing fluid delivery subsystems for semiconductor capital equipment. It offers gas and chemical delivery systems, which are key elements of the process tools used in the manufacturing of semiconductor devices. The firm also manufactures precision machined components, weldments, and proprietary products for use in fluid delivery systems for direct sales to its customers. The company was founded in 1999 and is headquartered in Fremont, CA.

Ichor Holdings Ltd

Ichor Holdings is surging after reporting positive earnings and future guidance, driving significant after-hours gains and enthusiasm from traders. The community is also highlighting recent insider buying by a Congresswoman, linking the company to favorable US semiconductor manufacturing policies and its role as a critical equipment supplier.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BNKR is trending with significant bullish momentum as the community anticipates it will drop a zero, fueled by recent exchange listings and its launch on Solana. The crypto's innovative AI-powered financial agent ecosystem on Base, including the new BankrWallet, is attracting strong interest and perceived as having substantial growth potential.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences is trending after positive interim data for its obesity candidate WVE-007 revealed differentiated fat loss with muscle preservation and potential for rare dosing, leading to significant analyst upgrades and M&A speculation. The community is actively discussing WVE-007's profile compared to existing GLP-1 therapies, amidst the company's recent $19 per share public offering to further advance its pipeline.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is trending amid widespread crypto market volatility, with its price experiencing significant fluctuations; however, the community remains divided, as many view current levels as a generational buying opportunity due to the network's robust on-chain activity, record transaction volumes, and its emerging role as a key AI infrastructure layer.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. It offers Alpha, Beta, Gamma, and orbital transfer vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 27, 2017 and is headquartered in Cedar Park, TX.

Firefly Aerospace Inc.

Firefly Aerospace is trending as the community anticipates its Alpha rocket launch and weighs its recent inclusion in the Russell indexes and a major SHIELD defense contract. Investors are actively debating its valuation and volatility, with broader sector excitement driven by the impending SpaceX IPO.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Recent news of Luckin Coffee's new premium flagship store and a key competitor ending aggressive pricing are fueling optimism for increased margins and market dominance. The community is eagerly discussing a potential uplisting to address the stock's perceived deep undervaluation amidst rapid growth and international expansion.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Inhibikase Therapeutics (NYSE:IKT) Earns Buy Rating from Analysts at Bank of America

Bank of America initiated coverage on shares of Inhibikase Therapeutics in a research report on Wednesday. They set a "buy" rating and a $6.00 price target on the stock...

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Given Consensus Recommendation of "Buy" by Brokerages

Shares of Inhibikase Therapeutics, Inc. (NASDAQ:IKT - Get Free Report) have been assigned a consensus rating of "Buy" from the five analysts that are presently covering the firm, Marketbeat reports...

Inhibikase Therapeutics (NYSE:IKT) Trading Up 1.2% - What's Next?

Inhibikase Therapeutics (NYSE:IKT) Shares Up 1.2% - What's Next...

Short Interest in Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Rises By 29.0%

Inhibikase Therapeutics, Inc. (NASDAQ:IKT - Get Free Report) was the target of a large increase in short interest during the month of December. As of December 15th, there was short interest totaling...

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Receives Consensus Rating of "Buy" from Brokerages

Inhibikase Therapeutics, Inc. (NASDAQ:IKT - Get Free Report) has earned a consensus recommendation of "Buy" from the five analysts that are presently covering the company, MarketBeat reports. One...

Inhibikase Therapeutics (NASDAQ:IKT) Raised to "Strong-Buy" at HC Wainwright

HC Wainwright raised shares of Inhibikase Therapeutics to a "strong-buy" rating in a research report on Friday...

Inhibikase Therapeutics (NASDAQ:IKT) Upgraded to Sell at Wall Street Zen

Wall Street Zen raised Inhibikase Therapeutics to a "sell" rating in a report on Saturday...

Inhibikase Therapeutics (NYSE:IKT) Receives Buy Rating from HC Wainwright

HC Wainwright reaffirmed a "buy" rating and set a $8.00 price objective on shares of Inhibikase Therapeutics in a research note on Friday...

Inhibikase Therapeutics (NASDAQ:IKT) Upgraded to Strong-Buy at Cantor Fitzgerald

Cantor Fitzgerald raised shares of Inhibikase Therapeutics to a "strong-buy" rating in a research note on Thursday...

Cantor Fitzgerald Initiates Coverage on Inhibikase Therapeutics (NYSE:IKT)

Cantor Fitzgerald initiated coverage on Inhibikase Therapeutics in a report on Thursday. They issued an "overweight" rating and a $4.00 price target on the stock...

Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in development of protein kinase inhibitor therapeutics to modify the course of Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. It also focuses on neurodegeneration and its lead program IkT-148009, an Abelson Tyrosine Kinase (c-Abl) inhibitor, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Ableson Tyrosine Kinases. The company was founded by Milton H. Werner in September 2008 and is headquartered in Wilmington, DE.

Inhibikase Therapeutics Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $HOOD earnings on Tuesday?

IKT
Inhibikase Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest IKT News

IKTInhibikase Therapeutics Inc